{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:38:21Z","timestamp":1787679501905,"version":"build-2784847793"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jlr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jlr.2025.100741","type":"journal-article","created":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T10:48:14Z","timestamp":1735987694000},"page":"100741","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Elevated levels of serum alpha-2-macroglobulin associate with diabetes status and incident CVD in type 1 diabetes"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8832-2845","authenticated-orcid":false,"given":"Baohai","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet K.","family":"Snell-Bergeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian H.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2756-2989","authenticated-orcid":false,"given":"W. Sean","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9208-6523","authenticated-orcid":false,"given":"Karin E.","family":"Bornfeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5246-0007","authenticated-orcid":false,"given":"Jay W.","family":"Heinecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jlr.2025.100741_bib1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"402","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jlr.2025.100741_bib2","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.2337\/db17-0093","article-title":"We know more than we can tell about diabetes and vascular disease: the 2016 edwin bierman award lecture","volume":"66","author":"Semenkovich","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.jlr.2025.100741_bib3","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s12265-012-9374-7","article-title":"Diabetic cardiovascular disease: getting to the heart of the matter","volume":"5","author":"Peterson","year":"2012","journal-title":"J.\u00a0Cardiovasc. Transl. Res."},{"key":"10.1016\/j.jlr.2025.100741_bib4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/jama.2014.16107","article-title":"Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality","volume":"313","author":"Orchard","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jlr.2025.100741_bib5","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s13300-019-0612-8","article-title":"Cardiovascular risk in type 1 diabetes mellitus","volume":"10","author":"Schofield","year":"2019","journal-title":"Diabetes Ther."},{"key":"10.1016\/j.jlr.2025.100741_bib6","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s40291-020-00483-6","article-title":"Importance of identifying novel biomarkers of microvascular damage in type 1 diabetes","volume":"24","author":"Marcovecchio","year":"2020","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.jlr.2025.100741_bib7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10557-016-6656-3","article-title":"Identifying new risk markers and potential targets: the value of the proteome","volume":"30","author":"Kontush","year":"2016","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.jlr.2025.100741_bib8","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1016\/j.jacc.2016.10.031","article-title":"Proteomics research in cardiovascular medicine and biomarker discovery","volume":"68","author":"Lam","year":"2016","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.jlr.2025.100741_bib9","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1074\/mcp.R200007-MCP200","article-title":"The human plasma proteome: history, character, and diagnostic prospects","volume":"1","author":"Anderson","year":"2002","journal-title":"Mol. Cell Proteomics"},{"key":"10.1016\/j.jlr.2025.100741_bib10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/14789450.2018.1402680","article-title":"Quantifying HDL proteins by mass spectrometry: how many proteins are there and what are their functions?","volume":"15","author":"Shao","year":"2018","journal-title":"Expert Rev. Proteomics"},{"key":"10.1016\/j.jlr.2025.100741_bib11","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGENETICS.117.001808","article-title":"Plasma proteomics for epidemiology: increasing throughput with standard-flow rates","volume":"10","author":"Yin","year":"2017","journal-title":"Circ. Cardiovasc. Genet."},{"key":"10.1016\/j.jlr.2025.100741_bib12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12933-024-02125-1","article-title":"Multiplexed MRM-based proteomics for identification of circulating proteins as biomarkers of cardiovascular damage progression associated with diabetes mellitus","volume":"23","author":"Piarulli","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.jlr.2025.100741_bib13","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1002\/pmic.201500543","article-title":"Parallel reaction monitoring using quadrupole-Orbitrap mass spectrometer: principle and applications","volume":"16","author":"Bourmaud","year":"2016","journal-title":"Proteomics"},{"key":"10.1016\/j.jlr.2025.100741_bib14","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jprot.2014.10.017","article-title":"Parallel reaction monitoring (PRM) and selected reaction monitoring (SRM) exhibit comparable linearity, dynamic range and precision for targeted quantitative HDL proteomics","volume":"113","author":"Ronsein","year":"2015","journal-title":"J.\u00a0Proteomics"},{"key":"10.1016\/j.jlr.2025.100741_bib15","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1172\/JCI127308","article-title":"Increased apolipoprotein C3 drives cardiovascular risk in type 1 diabetes","volume":"130","author":"Kanter","year":"2019","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.jlr.2025.100741_bib16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jacl.2020.10.006","article-title":"Association of apolipoprotein C3 with insulin resistance and coronary artery calcium in patients with type 1 diabetes","volume":"15","author":"Buckner","year":"2021","journal-title":"J.\u00a0Clin. Lipidol."},{"key":"10.1016\/j.jlr.2025.100741_bib17","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41569-021-00613-5","article-title":"Apolipoproteins in vascular biology and atherosclerotic disease","volume":"19","author":"Mehta","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.jlr.2025.100741_bib18","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1161\/CIRCULATIONAHA.108.770669","article-title":"Combined statin and niacin therapy remodels the high-density lipoprotein proteome","volume":"118","author":"Green","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jlr.2025.100741_bib19","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1161\/CIRCRESAHA.120.317178","article-title":"Diabetes impairs cellular cholesterol efflux from ABCA1 to small HDL particles","volume":"127","author":"He","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.jlr.2025.100741_bib20","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1074\/mcp.M115.054528","article-title":"Targeted proteomics identifies paraoxonase\/arylesterase 1 (PON1) and apolipoprotein Cs as potential risk factors for hypoalphalipoproteinemia in diabetic subjects treated with fenofibrate and rosiglitazone","volume":"15","author":"Ronsein","year":"2016","journal-title":"Mol. Cell Proteomics"},{"key":"10.1016\/j.jlr.2025.100741_bib21","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1021\/acs.jproteome.5b00060","article-title":"A\u00a0cluster of proteins implicated in kidney disease is increased in high-density lipoprotein isolated from hemodialysis subjects","volume":"14","author":"Shao","year":"2015","journal-title":"J.\u00a0Proteome Res."},{"key":"10.1016\/j.jlr.2025.100741_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2021.100135","article-title":"Altered HDL proteome predicts incident CVD in chronic kidney disease patients","volume":"62","author":"Shao","year":"2021","journal-title":"J.\u00a0lipid Res."},{"key":"10.1016\/j.jlr.2025.100741_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2022.100196","article-title":"Pulmonary surfactant protein B carried by HDL predicts incident CVD in patients with type 1 diabetes","volume":"63","author":"Shao","year":"2022","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2025.100741_bib24","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1161\/ATVBAHA.119.312556","article-title":"Albuminuria, the high-density lipoprotein proteome, and coronary artery calcification in type 1 diabetes mellitus","volume":"39","author":"Shao","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jlr.2025.100741_bib25","doi-asserted-by":"crossref","first-page":"178","DOI":"10.2337\/dc19-0772","article-title":"High concentration of medium-sized HDL particles and enrichment in HDL paraoxonase 1 associate with protection from vascular complications in people with long-standing type 1 diabetes","volume":"43","author":"Vaisar","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jlr.2025.100741_bib26","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1172\/JCI26206","article-title":"Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL","volume":"117","author":"Vaisar","year":"2007","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.jlr.2025.100741_bib27","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1161\/CIRCRESAHA.123.323100","article-title":"Imbalance of APOB lipoproteins and large HDL in type 1 diabetes drives atherosclerosis","volume":"135","author":"Kothari","year":"2024","journal-title":"Circ. Res."},{"key":"10.1016\/j.jlr.2025.100741_bib28","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nprot.2017.113","article-title":"Characterization of homodimer interfaces with cross-linking mass spectrometry and isotopically labeled proteins","volume":"13","author":"Lima","year":"2018","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jlr.2025.100741_bib29","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/bioinformatics\/btq054","article-title":"Skyline: an open source document editor for creating and analyzing targeted proteomics experiments","volume":"26","author":"MacLean","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jlr.2025.100741_bib30","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.2307\/2533444","article-title":"Robust variance estimation for the case-cohort design","volume":"50","author":"Barlow","year":"1994","journal-title":"Biometrics"},{"key":"10.1016\/j.jlr.2025.100741_bib31","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1093\/ije\/dyab258","article-title":"Predicting cardiovascular risk from national administrative databases using a combined survival analysis and deep learning approach","volume":"51","author":"Barbieri","year":"2022","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.jlr.2025.100741_bib32","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12966-022-01374-1","article-title":"Comparing the risk of cardiovascular diseases and all-cause mortality in four lifestyles with a combination of high\/low physical activity and healthy\/unhealthy diet: a prospective cohort study","volume":"19","author":"Kazemi","year":"2022","journal-title":"Int. J. Behav. Nutr. Phys. Act."},{"key":"10.1016\/j.jlr.2025.100741_bib33","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/(SICI)1096-9136(199703)14:3<242::AID-DIA340>3.0.CO;2-1","article-title":"Response of apolipoprotein AIV and lipoproteins to glycaemic control in young people with insulin-dependent diabetes mellitus","volume":"14","author":"Attia","year":"1997","journal-title":"Diabet Med."},{"key":"10.1016\/j.jlr.2025.100741_bib34","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1053\/meta.2001.25656","article-title":"Effect of the inflammation, chronic hyperglycemia, or malabsorption on the apolipoprotein A-IV concentration in type 1 diabetes mellitus and in diabetes secondary to chronic pancreatitis","volume":"50","author":"Quilliot","year":"2001","journal-title":"Metabolism"},{"key":"10.1016\/j.jlr.2025.100741_bib35","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12933-022-01452-5","article-title":"Plasma apolipoprotein concentrations and incident diabetes in subjects with prediabetes","volume":"21","author":"Croyal","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.jlr.2025.100741_bib36","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s00125-005-1760-0","article-title":"Cellular cholesterol efflux to plasma from moderately hypercholesterolaemic type 1 diabetic patients is enhanced, and is unaffected by simvastatin treatment","volume":"48","author":"de Vries","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.jlr.2025.100741_bib37","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1743-7075-11-28","article-title":"Patients with type 1 diabetes show signs of vascular dysfunction in response to multiple high-fat meals","volume":"11","author":"Lassenius","year":"2014","journal-title":"Nutr. Metab. (Lond.)"},{"key":"10.1016\/j.jlr.2025.100741_bib38","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.2337\/diabetes.51.11.3300","article-title":"Relationship of phospholipid transfer protein activity to HDL and apolipoprotein B-containing lipoproteins in subjects with and without type 1 diabetes","volume":"51","author":"Colhoun","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.jlr.2025.100741_bib39","doi-asserted-by":"crossref","first-page":"652","DOI":"10.2337\/diabetes.50.3.652","article-title":"Lipid transfer protein activities in type 1 diabetic patients without renal failure and nondiabetic control subjects and their association with coronary artery calcification","volume":"50","author":"Colhoun","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.jlr.2025.100741_bib40","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.thromres.2024.01.001","article-title":"High alpha-2-macroglobulin levels are a risk factor for cardiovascular disease events: a Moli-sani cohort study","volume":"234","author":"de Laat-Kremers","year":"2024","journal-title":"Thromb. Res."},{"key":"10.1016\/j.jlr.2025.100741_bib41","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1161\/ATVBAHA.120.314609","article-title":"Protein-defined subspecies of HDLs (High-Density lipoproteins) and differential risk of coronary heart disease in 4 prospective studies","volume":"40","author":"Sacks","year":"2020","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"10.1016\/j.jlr.2025.100741_bib42","doi-asserted-by":"crossref","first-page":"11539","DOI":"10.1016\/S0021-9258(18)80094-1","article-title":"Alpha-macroglobulins: structure, shape, and mechanism of proteinase complex formation","volume":"264","author":"Sottrup-Jensen","year":"1989","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jlr.2025.100741_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.803244","article-title":"Alpha-2-Macroglobulin in inflammation, immunity and infections","volume":"12","author":"Vandooren","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jlr.2025.100741_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-49144-7","article-title":"Molecular form and concentration of serum alpha(2)-macroglobulin in diabetes","volume":"9","author":"Yoshino","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jlr.2025.100741_bib45","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2147\/DMSO.S162008","article-title":"Proteomic analysis to identify candidate biomarkers associated with type 1 diabetes","volume":"11","author":"do Nascimento de Oliveira","year":"2018","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"10.1016\/j.jlr.2025.100741_bib46","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.3390\/biomedicines9091112","article-title":"Activated alpha 2-macroglobulin is a novel mediator of mesangial cell profibrotic signaling in diabetic kidney disease","volume":"9","author":"Trink","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.jlr.2025.100741_bib47","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1182\/blood.V78.9.2283.2283","article-title":"Alpha 2-macroglobulin binds and inhibits activated protein C","volume":"78","author":"Hoogendoorn","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.jlr.2025.100741_bib48","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1182\/blood.V78.9.2299.2299","article-title":"Alpha-2-macroglobulin may provide protection from thromboembolic events in antithrombin III-deficient children","volume":"78","author":"Mitchell","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.jlr.2025.100741_bib49","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1538-7836.2007.02534.x","article-title":"Role of elevated alpha2-macroglobulin revisited: results of a case-control study in children with symptomatic thromboembolism","volume":"5","author":"Beheiri","year":"2007","journal-title":"J.\u00a0Thromb. Haemost."},{"key":"10.1016\/j.jlr.2025.100741_bib50","doi-asserted-by":"crossref","first-page":"25764","DOI":"10.1016\/S0021-9258(18)35675-8","article-title":"The low density lipoprotein receptor-related protein\/alpha 2-macroglobulin receptor binds and mediates catabolism of bovine milk lipoprotein lipase","volume":"267","author":"Chappell","year":"1992","journal-title":"J.\u00a0Biol. Chem."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002222752500001X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002222752500001X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T06:45:23Z","timestamp":1740638723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002222752500001X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S002222752500001X"],"URL":"https:\/\/doi.org\/10.1016\/j.jlr.2025.100741","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated levels of serum alpha-2-macroglobulin associate with diabetes status and incident CVD in type 1 diabetes","name":"articletitle","label":"Article Title"},{"value":"Journal of Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jlr.2025.100741","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"100741"}}